Work

Cohort Study on Drug Survival and Tolerability of Adalimumab Biosimilar Transitioning: Pharmaceutical Properties Do Matter

Year: 2025

Type: article

Study design: Observational Study

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1002/cpt.70098

Authors: Amy C.D. Peeters, Maike H.M. Wientjes, Wieland D. Müskens, David F. Ten Cate, Laura C. Coates, Bart J. F. van den Bemt, Noortje van Herwaarden, Alfons A. den Broeder

Institutions: Sint Maartenskliniek, Sint Maartenskliniek, University of Oxford, Radboud University Nijmegen, Radboud University Medical Center

Language: English

Topic: Biosimilars and Bioanalytical Methods

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415468377

FWCI:

Cites: 22

Cited by:

Related to: